IP Verse

High Efficiency Particle Comprising Benefit Agent - EP2496678

The patent EP2496678 was granted to The Procter & Gamble on Dec 8, 2021. The application was originally filed on Nov 4, 2010 under application number EP10776895A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2496678

THE PROCTER & GAMBLE
Application Number
EP10776895A
Filing Date
Nov 4, 2010
Status
Patent Maintained As Amended
Nov 5, 2021
Publication Date
Dec 8, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PHARMA PATENTSOct 16, 2018-ADMISSIBLE

Patent Citations (38) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2007275866
DESCRIPTIONUS2008305982
DESCRIPTIONUS2009209661
DESCRIPTIONUS2009247449
DESCRIPTIONUS4430243
DESCRIPTIONUS5576282
DESCRIPTIONUS5595967
DESCRIPTIONUS5597936
DESCRIPTIONUS6225464
DESCRIPTIONUS6306812
DESCRIPTIONUS6326348
DESCRIPTIONWO0032601
INTERNATIONAL-SEARCH-REPORTEP1533364
INTERNATIONAL-SEARCH-REPORTJPH01168337
INTERNATIONAL-SEARCH-REPORTUS2007123442
INTERNATIONAL-SEARCH-REPORTUS2009209661
INTERNATIONAL-SEARCH-REPORTWO0141915
OPPOSITIONEP1358930
OPPOSITIONEP1393706
OPPOSITIONEP1533364
OPPOSITIONEP2298439
OPPOSITIONJPH01168337
OPPOSITIONUS2004138093
OPPOSITIONUS2004142828
OPPOSITIONUS2005153135
OPPOSITIONUS2006039934
OPPOSITIONUS2006287205
OPPOSITIONUS2007123442
OPPOSITIONUS2007138674
OPPOSITIONUS2009209661
OPPOSITIONUS2010055340
OPPOSITIONUS2940847
OPPOSITIONUS5486303
OPPOSITIONWO0141915
OPPOSITIONWO2007120547
OPPOSITIONWO2008006762
OPPOSITIONWO2008071649
OPPOSITIONWO2009016091

Non-Patent Literature (NPL) Citations (3) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
INTERNATIONAL-SEARCH-REPORT- DATABASE WPI, 0, Derwent World Patents Index, vol. 1989, no. 32, Database accession no. 1989-232177, XP002621650 & JPH01168337 A 19890703 (TERUMO CORP) [X] 1-7 * abstract * [I] 1-7
OPPOSITION- R. D. JAYANT et al., "Polyelectrolyte- coated alginate microspheres as drug delivery carriers for dexamethasone release", Drug Delivery, (20090000), vol. 16, no. 6, pages 331 - 340
OPPOSITION- R. D. JAYANT et al., "Polyelectrolyte- coated alginate microspheres as drug delivery carriers for dexamethasone release", Drug Delivery, (20090000), vol. 16, no. 6, pages 331 - 340, XP055525323

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents